NCT02731352 2022-01-20Study of Apatinib in Patients With Differentiated Thyroid CancerPeking Union Medical College HospitalPhase 2 Completed20 enrolled
NCT04612894 2020-11-03Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid CancerFudan UniversityPhase 2 Unknown31 enrolled
NCT03300765 2017-10-03Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid CancerFudan UniversityPhase 2 Unknown20 enrolled